The members of President-elect Joe Biden’s coronavirus advisory board have warned that the administration’s refusal to allow the transition would hurt their anti-COVID plans in different ways.
Nearly two weeks after the presidential election, Biden's transition team is still deprived of consulting with the health officials or accessing the real-time data, an issue that has forced them to rely on piecemeal data from public sources.
“Not only do we need cooperation in order to ensure that we have a good vaccine delivery plan — we really need it across the board,” said Vivek Murthy, one of the co-chairs of the advisory board.
“That cooperation will impact how effective we are at closing the testing gap, ensuring that hospitals and doctors and nurses have enough protective equipment like masks and gloves and make sure we have enough syringes and swabs to proceed with a vaccination campaign,” he added.
Joe Biden had previously warned that the administration’s delay in recognizing him as the winner of the election could hamper his team’s ability to create a national vaccination campaign.
On Wednesday, for the 15th consecutive day, the US reported more than 100,000 daily COVID-19 infections. Each day, hundreds of Americans continue to lose their battle against the virus, with at least eleven days this month topping a 1,000 daily death toll.
Meanwhile, Moderna biotechnology company announced this week that its vaccine has proved to be more than 94% effective. Pfizer and BioNTech also declared that their vaccine is more than 95% effective in the final analysis of its massive Phase 3 trial.